Patent: 5,712,128

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,712,128

Title:	Enzymatic RNA molecules
Abstract:	Nucleic acid molecule having an RNA substrate cleaving enzymatic activity which cleaves a separate RNA substrate at a cleavage site. The nucleic acid molecule includes an RNA substrate binding portion which base pairs with the RNA substrate only 3\' of the cleavage site, and an enzymatic portion (which may include a part or all of the RNA substrate binding portion) having the enzymatic activity. The nucleic acid molecule is able to base pair with the RNA substrate only 3\' of the cleavage site, and cause cleavage of the RNA substrate at that cleavage site. The nucleic acid molecule can be either linear or circular. A general method for forming circular RNA in vivo and in vitro is provided.
Inventor(s):	Been; Michael D. (Durham, NC), Rosenstein; Sarah P. (Durham, NC), Perrotta; Anne T. (Garner, NC)
Assignee:	Duke University (Durham, NC)
Application Number:	08/434,453
Patent Claims:	see list of patent claims

Details for Patent 5,712,128

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04	➤ Sign Up	Duke University (Durham, NC)	2015-01-27	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04	➤ Sign Up	Duke University (Durham, NC)	2015-01-27	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04	➤ Sign Up	Duke University (Durham, NC)	2015-01-27	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 5,712,128

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	9314218	Jul 22, 1993
United States of America	5625047	Apr 29, 1997
Japan	H07502898	Mar 30, 1995
European Patent Office	0623171	Feb 12, 1997
European Patent Office	0623171	Nov 09, 1994
Canada	2127461	Jul 22, 1993
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.